Critical dose in levamisole-mediated regression of mammary carcinoma.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000276:immunology; D000818:Animals; D005260:Female; D007978:Levamisole / Q000008:administration & dosage* / Q000627:therapeutic use; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D051381:Rats
D007978:Levamisole